Literature DB >> 15636450

Detection of cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae DNA in carotid atherosclerotic plaques by the polymerase chain reaction.

George Latsios1, Angelica Saetta, Nikolaos V Michalopoulos, Emmanuil Agapitos, Efstratios Patsouris.   

Abstract

OBJECTIVE: Cytomegalovirus (CMV), Helicobacter pylori (H. pylori) and Chlamydia pneumoniae (C. pneumoniae) have been associated with human atherosclerosis. The reported rates of detection within atherosclerotic lesions by PCR vary widely for all of these pathogens. We investigated their presence in carotid atherosclerotic plaques. METHODS AND
RESULTS: Eighty-three carotid atherosclerotic specimens were available for examination. The highly sensitive polymerase chain reaction method was employed with primers specific for each agent. The presence of CMV DNA was not detected in any of the examined samples (0%), whereas the presence of H. pylori DNA was observed in two out of eighty-three cases (2.4%). C. pneumoniae DNA was found in eighteen (21.6%) of the plaques studied.
CONCLUSIONS: H. pylori DNA was detected in a very small subset of atherosclerotic plaques, whereas CMV DNA was not detected in any of the plaques studied. C. pneumoniae DNA was found in a significant number of our atherosclerotic plaques. Further studies are needed to clarify the possible causal relation between infection by these organisms and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15636450     DOI: 10.2143/AC.59.6.2005249

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  5 in total

Review 1.  Infection and Atherosclerosis Development.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Arch Med Res       Date:  2015-05-21       Impact factor: 2.235

2.  Presence of Chlamydia pneumoniae in patients with and without atherosclerosis.

Authors:  E Podsiadły; J Przyłuski; A Kwiatkowski; M Kruk; M Wszoła; R Nosek; W Rowiński; W Ruzyłło; S Tylewska-Wierzbanowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

3.  Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting.

Authors:  Dimas T Ikeoka; Carolina Z Vieira; Pedro A Lemos; Tania V Strabelli; Expedito E Ribeiro da Silva; Marco A Perin; Andrea Groselj-Strele; Beate Tiran; Andreas Tiran; Bruno Caramelli
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

4.  Absence of Bacteria on Coronary Angioplasty Balloons from Unselected Patients: Results with Use of a High Sensitivity Polymerase Chain Reaction Assay.

Authors:  Gorm Mørk Hansen; Martin Nilsson; Claus Henrik Nielsen; Palle Holmstrup; Steffen Helqvist; Tim Tolker-Nielsen; Michael Givskov; Peter Riis Hansen
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

Review 5.  Microbiota, Immune Subversion, and Chronic Inflammation.

Authors:  Carolyn D Kramer; Caroline Attardo Genco
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.